Primex Pharmaceuticals

Primex Pharmaceuticals is a leading global innovative anaesthesia company, expanding in paediatric pharmaceuticals. The company brings a portfolio of strong, trusted anaesthesia products to help patients undergo a wide range of medical procedures, including a novel, oral solution for paediatric sedation now approved in several markets in the European Union. Primex Pharmaceuticals will continue to identify and bring to the market new medications that complete the Triad of Anaesthesia. In addition, the Group includes a complimentary range of local anaesthetics and dental products under the OGNA® brand. Primex Pharmaceuticals' global partner network operates in over 40 countries. The company is headquartered in Switzerland, and all Primex products are manufactured in Europe. Primex Pharmaceuticals has proven underlying business operations and a history of strong revenue growth. The last investment in Primex Pharmaceuticals was a Series A investment at 17 April 2014 from Finnvera Venture Capital. For more information, visit www.primexpharma.com.